title: Stimulus-selective induction of the orphan nuclear receptor NGFIB underlies different influences of angiotensin II and potassium on the human adrenal gland zona glomerulosa-specific 3β-HSD isoform gene expression in adrenocortical H295R cells.
abstract: In the adrenal, the type I 3β-hydroxysteroid dehydrogenase (HSD3B1) is expressed exclusively in the zona glomerulosa (ZG), where aldosterone is produced. Angiotensin II (AngII) and potassium (K(+)) are the major physiological regulators of aldosterone synthesis. However, their respective roles in regulation of aldosterone synthesis are not fully defined, particularly in terms of transcriptional regulation of steroidogenic enzyme genes. We previously showed that AngII can stimulate expression of HSD3B1. But, K(+) responsiveness of this gene has remained unexplored. Here, we report that K(+) stimulation lacks the ability to induce HSD3B1 expression in human adrenocortical H295R cells. Both AngII and K(+) were able to enhance transcription of the aldosterone synthase gene (CYP11B2). Promoter analysis revealed that although both AngII and K(+) activate transcription from the Ca(2+)/cAMP-responsive element (CRE) located in the CYP11B2 promoter, the orphan nuclear receptor NGFIB-responsive element (NBRE) located in the HSD3B1 promoter fails to respond to K(+), being only able to enhance transcription after AngII treatment. We found that induction of de novo protein synthesis of NGFIB occurs only after AngII treatment. This sharply contrasts with the phosphorylation that occurs in response to both AngII and K(+) on the CREB/ATF family transcription factor ATF2. Chromatin immunoprecipitation assay confirmed that the NGFIB protein occupies the HSD3B1 promoter only after AngII, while ATF2 binds to the CYP11B2 promoter in response to both AngII and K(+). These data provide evidence that downstream signals from AngII and K(+) can be uncoupled in the regulation of HSD3B1 in the human adrenocortical H295R cells.
authors.affiliation: Department of Systems Biology, Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto 606-8051, Japan.
authors.forename: Daisuke
authors.initials: D
authors.lastname: Yarimizu
authors.forename: Masao
authors.initials: M
authors.lastname: Doi
authors.forename: Takumi
authors.initials: T
authors.lastname: Ota
authors.forename: Hitoshi
authors.initials: H
authors.lastname: Okamura
mesh_terms: D015096:3-Hydroxysteroid Dehydrogenases / Q000235:genetics*; D000809:Angiotensins / Q000494:pharmacology*; D002460:Cell Line; D015870:Gene Expression; D005786:Gene Expression Regulation / Q000187:drug effects; D006801:Humans; D057105:Nuclear Receptor Subfamily 4, Group A, Member 1 / Q000819:agonists* / Q000378:metabolism; D011188:Potassium / Q000494:pharmacology*; D011401:Promoter Regions, Genetic / Q000187:drug effects; D015384:Zona Glomerulosa / Q000187:drug effects / Q000378:metabolism*
chemical_list: D000809:Angiotensins; D057105:Nuclear Receptor Subfamily 4, Group A, Member 1; D015096:3-Hydroxysteroid Dehydrogenases; D011188:Potassium